MORGAN STANLEY - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$229,433
-13.4%
78,305
-15.5%
0.00%
Q2 2023$265,037
+13.4%
92,670
+22.5%
0.00%
Q1 2023$233,743
+125.8%
75,645
+54.2%
0.00%
Q4 2022$103,514
-32.3%
49,059
+4.5%
0.00%
Q3 2022$153,000
+18.6%
46,968
+17.0%
0.00%
Q2 2022$129,000
-57.0%
40,143
-5.8%
0.00%
Q1 2022$300,000
-55.0%
42,603
-53.6%
0.00%
Q4 2021$666,000
-20.7%
91,817
+26.9%
0.00%
Q3 2021$840,00072,3430.00%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders